BELLUCCI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 4.623
EU - Europa 3.266
AS - Asia 1.586
SA - Sud America 157
OC - Oceania 31
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.692
Nazione #
US - Stati Uniti d'America 4.592
RU - Federazione Russa 994
PL - Polonia 935
SG - Singapore 454
CN - Cina 334
HK - Hong Kong 323
SE - Svezia 287
IE - Irlanda 277
IT - Italia 242
VN - Vietnam 171
KR - Corea 155
DE - Germania 136
BR - Brasile 135
UA - Ucraina 121
FI - Finlandia 99
GB - Regno Unito 76
IN - India 61
AU - Australia 31
FR - Francia 31
ID - Indonesia 14
CA - Canada 13
MX - Messico 13
JO - Giordania 12
TR - Turchia 12
AR - Argentina 11
BE - Belgio 11
CI - Costa d'Avorio 11
ES - Italia 11
NL - Olanda 11
CH - Svizzera 10
BD - Bangladesh 9
JP - Giappone 8
IQ - Iraq 7
RO - Romania 6
SC - Seychelles 5
CO - Colombia 4
HR - Croazia 4
EC - Ecuador 3
HU - Ungheria 3
IL - Israele 3
KE - Kenya 3
LT - Lituania 3
CR - Costa Rica 2
CY - Cipro 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NP - Nepal 2
PK - Pakistan 2
PY - Paraguay 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
AT - Austria 1
BG - Bulgaria 1
CL - Cile 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
HN - Honduras 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MA - Marocco 1
MY - Malesia 1
NG - Nigeria 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 9.692
Città #
Santa Clara 1.043
Warsaw 930
Ashburn 562
Fairfield 321
Chandler 301
Singapore 288
Dublin 277
Hong Kong 268
Woodbridge 190
Jacksonville 171
Cambridge 155
Seattle 153
Seoul 153
Houston 146
Wilmington 131
Dong Ket 124
Buffalo 98
Beijing 94
Ann Arbor 91
Los Angeles 71
Princeton 69
Boston 60
Altamura 54
Mumbai 51
Hefei 45
Lawrence 41
Boardman 40
Florence 39
Munich 32
Dallas 31
Melbourne 31
The Dalles 25
Moscow 24
Council Bluffs 23
New York 21
Shanghai 21
Turku 21
Falls Church 20
Ho Chi Minh City 20
Kent 20
Medford 20
Guangzhou 19
Norwalk 17
Redondo Beach 16
Paris 15
Washington 14
Helsinki 13
San Diego 13
São Paulo 12
West Jordan 12
Abidjan 11
Brussels 11
Dearborn 10
Milan 10
Bern 9
Hanoi 9
Hillsboro 9
Jakarta 9
Clifton 8
Frankfurt am Main 8
Philadelphia 8
Phoenix 8
Rome 8
Tokyo 8
Toronto 8
Verona 8
Barcelona 7
Yubileyny 7
Andover 6
Chicago 6
Frankfurt Am Main 6
London 6
Charlotte 5
Lappeenranta 5
Redwood City 5
Stockholm 5
Ankara 4
Auburn Hills 4
Belo Horizonte 4
Curitiba 4
Dhaka 4
Düsseldorf 4
Genoa 4
Izmir 4
Montreal 4
Amherst 3
Atlanta 3
Baghdad 3
Brasília 3
Brooklyn 3
Denver 3
Duque de Caxias 3
Haiphong 3
Las Vegas 3
Laurel 3
Mexico City 3
Nairobi 3
Nuremberg 3
Ribeirão Preto 3
Rio de Janeiro 3
Totale 6.687
Nome #
Antinociceptive property of the nicotinic agonist AG4 in rodents 498
Antisense knockdowns of M1 receptors induces transient anterograde amnesia in mice 307
Antinociceptive profile of SM21: a novel analgesic with a presynaptic cholinergic mechanism of action 299
Design, synthesis and preliminary pharmacological evaluation of 1,4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs. 270
Memory facilitation with atropine: a paradoxical effect 269
In vitro characterization of a novel, potent and selective M3 antagonist 259
Antinociceptive and antiamnesic properties of the presynaptic amplifier PG-9 259
MOLECULAR MODULATION OF MUSCARINIC ANTAGONISTS. SYNTHESIS AND AFFINITY PROFILE OF 2,2-DIPHENYL-2-ETHYLTHIO-ACETIC ACID ESTERS DESIGNED TO PROBE THE BINDING SITE CAVITY 230
Multidrug resistance (MDR) reversers: High activity and efficacy in a series of asymmetrical N,N-bis(alkanol)amine aryl esters 210
(1,3-Dioxolane)- and (1,3-oxathiolane)-2-pyrrolidines: molecular hybrids with potential anti-Alzheimer activity 198
FURTHER STRUCTURE-ACTIVITY RELATIONSHIPS IN THE SERIES OF TROPANYL ESTERS ENDOWED WITH POTENT ANTINOCICEPTIVE ACTIVITY 193
New structure–activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR) 182
Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist. 181
Antagonisti muscarinici a struttura 1,3-ossatiolano-2-pirrolidinica 177
1,4-Diazabicyclo[4.3.0]nonan-9-ones and 1,4-diamidopiperazines as new classes of highly potent nootropic drugs 177
ANALGESIC, ANTIMUSCARINIC ACTIVITY AND ENANTIOSELECTIVITY OF THE FOUR ISOMERS OF 3-QUINUCLIDINYL TROPATE AS COMPARED WITH THE ENANTIOMERS OF HYOSCYAMINE 175
Carbachol dimers as homobivalent modulators of muscarinic receptors 174
SYNTHESIS, AFFINITY PROFILE AND FUNCTIONAL ACTIVITY OF MUSCARINIC ANTAGONISTS WITH A 1-METHYL-2-(2,2-ALKYLARYL-1,3-OXATHIOLAN-5-YL)PYRROLIDINE STRUCTURE 171
SYNTHESIS, CHARACTERIZATION AND PHARMACOLOGICAL PROFILE OF TROPICAMIDE ENANTIOMERS 165
1,4-Diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs 165
Synthesis and Cholinergic Affinity of Diastereomeric and Enantiomeric Isomers of 1-Methyl-2-(2-methyl-1,3-dioxolan-4-yl)-pyrrolidine, 1-Methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine and of Their Iodomethylates 163
DIFFERENTIAL ANALGESIC ACTIVITY OF THE ENANTIOMERS OF ATROPINE DERIVATIVES DOES NOT CORRELATE WITH THEIR MUSCARINIC SUBTYPE SELECTIVITY 159
Designing selective modulators for the nicotinic receptor subtypes: challenges and opportunities 153
Muscarine-like compounds derived from a pyrolysis product of cellulose 152
MOLECULAR MODULATION OF MUSCARINIC ANTAGONISTS. SYNTHESIS AND PHARMACOLOGICAL PROFILE OF 2,2-DIPHENYL-2-ETHYLTHIOACETIC AND 3,3-DIPHENYL-3-ETHYLTHIOPROPIONIC ACID DERIVATIVES CHARACTERIZED BY A DIPEPTIDE SPACER 150
Muscarinic antagonists with multiple stereocenters: synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives 147
Carbachol dimers with primary carbamate groups as homobivalent modulators of muscarinic receptors 146
New Rigid Nicotine Analogues, Carrying a Norbornane Moiety, Are Potent Agonists of α7 and α3∗ Nicotinic Receptors 141
Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives. 140
Attività analgesica e antimuscarinica ed enantioselettività dei quattro isomeri del tropato del 3-chinuclidinolo messe a confronto con gli enantiomeri della iosciamina 136
Design, synthesis and preliminary pharmacological evaluation of 4-aminopiperidine derivatives as N-type calcium channel blockers active on pain and neuropathic pain 136
Structure-activity relationships in 2,2-diphenyl-2-ethylthioacetic acid esters: unexpected agonistic activity in a series of muscarinic antagonists. 134
NEGATIVE INOTROPIC ACTIVITY OF PARA-SUBSTITUTED DIETHYL BENZYL PHOSPHONATES RELATED TO FOSTEDIL 133
Synthesis, Affinity Profile and Functional Activity of Potent Chiral Muscarinic Antagonists with a Pyrrolidinylfuran Structure 129
Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists 127
Differential analgesic activity of the enantiomers of atropine derivatives does not correlate with their muscarinic subtype selectivity 127
Modulazione molecolare di antagonisti muscarinici. Sintesi e valutazione farmacologica preliminare di esteri amminoalchil piperazinici e piperidinici dell'acido 2,2-difenil-2-etiltioacetico 127
New insights in the metabolism of Oxybutynin: evidence of N-oxidation of propargylamine moiety and rearrangement to enaminoketone 127
New quinoline derivatives as nicotinic receptor modulators 124
NEGATIVE INOTROPIC AND CALCIUM ANTAGONISTIC ACTIVITY OF ALKYL AND ARYLALKYL PHOSPHONATES 121
Highly chiral muscarinic ligands: synthesis and affinity of diastereomeric and enantiomeric isomers of 1-methyl-2-(2-methyl-1,3-oxathiolane-5-yl)pyrrolidine 3-sulfoxides and their methyl iodides 117
synthesis, chiral HPLC separation and pharmacological characterization of muscarinic furan derivatives 114
New multidrug resistance (MDR) agents endowed with good potency and efficacy 114
Design, Synthesis and binding affinity of carbachol dimers as bitopic ligands 111
Molecular modulation of muscarinic antagonists. Synthesis and pharmacological profile of 2,2-diphenyl-2-ethylthioacetic acid and 3,3-diphenyl-3-ethylthiopropionic acid derivatives characterized by a dipeptide spacer 110
Sintesi e valutazione farmacologica di derivati furanici e tetraidrofuranici a potenziale azione muscarinica 109
SAR STUDIES IN THE FIELD OF CA2+ ANTAGONISTS. EFFECT OF MODIFICATIONS AT THE TETRASUBSTITUTED CARBON OF VERAPAMIL-LIKE COMPOUNDS 107
New N-alkanol-N-cyclohexanolamine aryl ester derivatives as reverting agents of Multidrug Resistance (MDR) 107
SEARCH FOR NEW CA2+ ANTAGONISTS. LIPOPHILIC OXIMES AND PHOSPHONATES 106
New potent piperazine and aminopiperidine derivatives as reverting agents of Multidrug Resistance (MDR) 106
Flavonoid aminoesters acting as reversing agents of Pgp-dependent multidrug resistance (MDR) 106
Design, Synthesis and binding affinity of new ligands for the central nicotinic receptors 104
New analogues of the potent nootropic drug DM235: 2-or 3-phenylpiperazines with limited conformational flexibility 98
Antinociceptive and antiamnesic properties of the nicotinic agonist AG-4 97
Hybridized and isosteric analogs of N1-acetyl-N4-dimethyl-piperazinium iodide (ADMP) and N1-phenyl-N4-dimethyl-piperazinium iodide (DMPP) with central nicotinic action 96
Design, synthesis and preliminary pharmacological evaluation of alkylderivatives of 4-aminopiperidine as N-type calcium channels blockers 96
Unexpected Multidrug Resistance (MDR) reverting activity of a new series of N,N-bis(arylalkanol)amine aryl esters 95
Sintesi e affinità per i recettori colinergici degli stereoisomeri della 1-metil-2-(2-metil-1,3-diossolan-4-il)pirrolidina, della 1-metil-2-(2-metil-1,3-ossatiolan-5-il)pirrolidina e dei loro iodometilati 95
Synthesis and pharmacological characterization of diastereomeric and enantiomeric isomers of 1-methyl-2-(2-methyl-1,3-oxathiolane-5-yl)pyrrolidine 3-sulfoxides and their methyl iodides 94
Piperazine derivatives possessing nootropic activity 79
Unexpected agonistic activity in a series of muscarinic antagonists 77
The double life of UNIFI nootropics 63
Hybridized and isosteric analogs of N1-acetyl-N4-dimethylpiperazinium iodide (ADMP), N1-phenyl-N4-dimethylpiperazinium iodide (DMPP) with central nicotinic action 62
Hybridized and isosteric analogs of N1-acetyl-N4-dimethylpiperazinium iodide (ADMP), N1-phenyl-N4-dimethylpiperazinium iodide (DMPP) with central nicotinic action 61
Progettazione, Sintesi e studio di molecular modeling di nuovi ligandi nicotinici 59
Pharmacological profile of the enantiomers of tropicamide 52
Totale 9.766
Categoria #
all - tutte 24.733
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.733


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021541 0 0 0 0 0 93 35 56 56 99 33 169
2021/2022441 15 69 18 13 16 19 28 12 15 18 87 131
2022/20231.201 113 180 53 96 84 232 170 72 127 12 42 20
2023/2024651 8 50 76 31 24 60 17 315 7 23 17 23
2024/20252.843 99 291 192 413 825 456 24 189 102 58 101 93
2025/20261.492 313 415 235 160 345 24 0 0 0 0 0 0
Totale 9.766